← Back to Search

Other

Acupuncture for Sickle Cell Disease Pain Management

N/A
Recruiting
Research Sponsored by Indiana University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age range: 14-17 (Adolescents) and 18-80 (Adults)
Diagnosed with SCD (includes but not limited to SS, SC or other type) and experiencing chronic pain in the past 6 months or vaso-occlusive crisis (VOC) in the past 12 months
Must not have
Significant visual, motor, or auditory impairment that would interfere with ability to perform study visits-related activities
Presence of a concurrent autoimmune or inflammatory disease that causes pain or any other chronic pain condition with pain greater than sickle pain
Timeline
Screening 3 weeks
Treatment Varies
Follow Up changes of pain-related quality of life scores from baseline to post-treatment time point (approximately 5 weeks interval), as well as monthly follow-up visits till the 12th month of last in-person visit.
Awards & highlights
No Placebo-Only Group

Summary

This trial will test if acupuncture can help relieve pain for patients with sickle cell disease, and if so, try to understand how it works.

Who is the study for?
This trial is for right-handed individuals aged 14-80 with sickle cell disease (SCD), experiencing chronic pain or vaso-occlusive crises. Participants must be fluent in English, able to travel for study visits, and willing to limit new pain treatments during the trial. Pregnant/nursing individuals, those with coagulation issues, recent acupuncture treatment, certain chronic conditions or severe psychiatric illnesses are excluded.
What is being tested?
The study tests the effectiveness of acupuncture as a pain management method in SCD patients against a sham procedure (placebo). It involves scheduled visits for questionnaires and various tests like MRI and EEG over five weeks with up to two acupuncture sessions weekly.
What are the potential side effects?
While not specified here, common side effects of acupuncture may include soreness, minor bleeding or bruising at needle sites. The risk of serious side effects is low but could involve injury if needles touch organs.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 14 and 80 years old.
Select...
I have sickle cell disease and have had chronic pain or a pain crisis in the last year.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I do not have severe vision, hearing, or movement problems affecting study activities.
Select...
I have a chronic pain condition more severe than my sickle cell pain.
Select...
I have a blood clotting issue that may make acupuncture unsafe for me.
Select...
I am suspected of or confirmed to have Covid-19.
Select...
I have nerve damage that affects my daily activities.
Select...
I have had vascular surgery on my legs or currently have leg circulation problems.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~changes of pain-related quality of life scores from baseline to post-treatment time point (approximately 5 weeks interval), as well as monthly follow-up visits till the 12th month of last in-person visit.
This trial's timeline: 3 weeks for screening, Varies for treatment, and changes of pain-related quality of life scores from baseline to post-treatment time point (approximately 5 weeks interval), as well as monthly follow-up visits till the 12th month of last in-person visit. for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Functional brain connectivity characteristics
Somatosensory function
Secondary study objectives
Adult Sickle Cell Quality Measure (ASCQ-ME) Questionnaire
Brain metabolites characteristics
Brief Pain Inventory (BPI) Questionnaire
+8 more
Other study objectives
Blood hemoglobin level
Brain hemodynamic activity
Brain structural characteristics
+5 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Group I: Needling AcupunctureExperimental Treatment1 Intervention
Group II: Laser AcupunctureExperimental Treatment1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
laser acupuncture
2013
Completed Phase 3
~90

Find a Location

Who is running the clinical trial?

National Center for Complementary and Integrative Health (NCCIH)NIH
859 Previous Clinical Trials
672,250 Total Patients Enrolled
Indiana UniversityLead Sponsor
1,039 Previous Clinical Trials
1,218,938 Total Patients Enrolled

Media Library

Acupuncture (Other) Clinical Trial Eligibility Overview. Trial Name: NCT05045820 — N/A
Sickle Cell Disease Research Study Groups: Needling Acupuncture, Laser Acupuncture
Sickle Cell Disease Clinical Trial 2023: Acupuncture Highlights & Side Effects. Trial Name: NCT05045820 — N/A
Acupuncture (Other) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05045820 — N/A
~15 spots leftby May 2025